Dartmouth Cancer Center

Why the Dartmouth Cancer Center

The Dartmouth Cancer Center (DCC) is a premier, nationally recognized leader in oncology care and research, providing critical services to our patients across a five-state catchment area and advancing medical discoveries that impact the world.

Dartmouth Cancer Center is a Press Ganey 2023 HX Pinnacle of Excellence Award® recipient for human experience in medical practice and is one of the nation’s premier facilities for cancer treatment and research. It is one of only 56 National Cancer Institute-designated comprehensive cancer centers in the United States.

Dartmouth Cancer Center (DCC) is an NCI-Designated Comprehensive Cancer Center and the only one based in northern New England. The DCC is integrated with the Dartmouth Health and Geisel School of Medicine at Dartmouth College. That means academic rigor, cutting-edge science, and community reach in one ecosystem. Patients here benefit from research-driven care and access to clinical trials; care at NCI-designated centers has been associated with up to a 25% improvement in long-term survival.

In June 2025 the National Cancer Institute (NCI) renewed DCC’s Comprehensive designation through 2029, underscoring program depth, scientific leadership, and regional impact. We are one of 57 such centers nationally to achieve this elite designation.

Our mission is bold and we want you to join us.

The work you’ll do

  • A large volume center
    DCC physicians and researchers collaborate across interdisciplinary programs to care for 4000+ new and 23,000+ current cancer patients annually (2024 figures), translating discovery to the bedside.
  • Research at scale
    We average 250+ active research projects led by 135 cancer scientists and are supported by $68M/year in federal and other funding spanning prevention, population science, therapeutics, and quality of life.
  • Clinical trials leadership
    DCC is an NCI National Clinical Trials Network Lead Academic Participating Site, with coordinated support from the Office of Clinical Research for investigator-initiated, industry, and cooperative group studies.

Scientific strengths & Infrastructure

  • Research programs
    Cancer Population Sciences; Cancer Signaling, Genomes & Networks; Immunology & Cancer Immunotherapy and Translational Engineering in Cancer.
  • Shared resources
    Genomics & Molecular Biology; Immune Monitoring & Flow Cytometry; Preclinical Imaging & Microscopy; Mouse Modeling; Trace Elements Analysis; Clinical Pharmacology; Pathology and Biostatistics & Bioinformatics.
  • Translational edge
    The Center for Surgical Innovation integrates intraoperative MRI/CT with OR workflows enabling imaging-guided trials and technology validation side-by-side with care.
  • New investments
    The Byrne Family Cancer Research Institute launched with a $25M lead gift to accelerate bold science, expand trials, and recruit/retain top MD/PhD talent.

Current Openings at Dartmouth Cancer Center